Case Study: Cryolife, Inc. Cyrolife

The company that I chose was Cryolife, Inc. Cyrolife was founded in 1984 as a processor of the preservation of human heart valves for adults and children that needed heart valve reconstruction (Cryolife, 2015). The company has expanded to provide biomedical products for cardiac and vascular products, surgical adhesives, and processed human cardiac and vascular transplants (Cryolife, 2015). Cyrolife is one of the few publically traded tissue processors within the transplant industry and operates the business as a for-profit entity. According to the MD&A, the company had annual revenues of $144.6 million and produced $8.1 million in cash flows during the 2014 fiscal year. This was a 3% increase from the previous fiscal year. Since it is against